Böhm N, Moser B
Beitr Pathol. 1976 May;157(3):283-300.
Administration of phenobarbital to rats and mice is well known to cause enlargement of the liver, where the drug is metabolized by hydroxylation and oxydation. The increase of the liver weight is thought to be due to and enlargement of the individual hepatocytes (hypertrophy) caused by an augmentation of the smooth endoplasmic reticulum, as well as to cell multiplication (hyperplasia). The present investigation deals with the nuclear DNA content of mouse hepatocytes during and after administration of different doses of phenobarbital. The data are related to liver weight with due consideration of mitotic activity and cell loss by necrobiosis.
172 five to six weeks old male albino NMRI mice with a body weight of 23 to 33 gms were randomly divided into four groups, one of which served as the controls. The three test groups received 75 mg and 150 mg phenobarbital per 1 kg body weight intraperitoneally once every day for a total of 10 days. Thereafter the administration of the drug was discontinued. Beginning with the third day of the experiment 3 animals of each group were sacrificed by exsanguination every secound day after their body weight had been carefully determined. Then the liver weights were measured. The nuclear DNA content of the hepatocytes was determined from liver smears by means of acriflavine-Feulgen fluorescence cytophotometry. The number of mitotic figures and of necrobiotic liver cells was counted in histologic sections.
With animals receiving 150 mg and 100 mg phenobarbital per 1 kg body weight a rapid increase of the relative liver weight (up to 74% above the controls) was observed, which was reduced back to normal levels within 10 days after discontinuation of the drug. Parallel with the increase of the liver weight a striking DNA-polyploidisation of the liver nuclei occurred which proved to be reversible during the reduction phase. Mitotic figures were found only in the initial phase of the experiment (third to fifth day), while the number of necrobiotic hepatocytes was increased after the drug was discontinued. Similar but markedly less pronounced effects were encountered with animals of the 75 group.
It is concluded that the increase of the liver weight of mice after phenobarbital administration is partly due to cell multiplication (hyperplasia) - as is shown by a high number of mitotic figures in the initial phase of the experiment-, partly due to the enlargement of hepatocytes with concommitant polyploidisation of the muclei (hypertrophy). When the drug administration is discontinued the liver weights return to normal levels within 10 days. Since at the same time the number of high-ploidy nuclei is reduced with no evidence of an increased mitotic activity, the reduction of the liver weight should be partly caused by an elimination of high-ploidy hepatocytes, which are no longer required after the hyperfunctional stimulus has ceased...
众所周知,给大鼠和小鼠施用苯巴比妥会导致肝脏肿大,药物在肝脏中通过羟基化和氧化作用进行代谢。肝脏重量的增加被认为是由于平滑内质网增多导致单个肝细胞肿大(肥大),以及细胞增殖(增生)。本研究探讨了在施用不同剂量苯巴比妥期间及之后小鼠肝细胞的核DNA含量。这些数据与肝脏重量相关,并适当考虑了有丝分裂活性和细胞坏死导致的细胞损失。
172只体重23至33克、五到六周龄的雄性白化NMRI小鼠被随机分为四组,其中一组作为对照组。三个试验组每1千克体重每天腹腔注射75毫克和150毫克苯巴比妥,共注射10天。此后停止给药。从实验第三天开始,在仔细测定每组动物体重后,每隔一天处死3只动物,放血致死。然后测量肝脏重量。通过吖啶黄素 - 福尔根荧光细胞光度法从肝脏涂片测定肝细胞的核DNA含量。在组织学切片中计数有丝分裂象和坏死肝细胞的数量。
给每1千克体重注射150毫克和100毫克苯巴比妥的动物,观察到相对肝脏重量迅速增加(比对照组高出74%),在停药后10天内恢复到正常水平。随着肝脏重量的增加,肝细胞核出现显著的DNA多倍体化,在减轻阶段证明是可逆的。仅在实验初期(第三天至第五天)发现有丝分裂象,而停药后坏死肝细胞数量增加。75毫克组的动物也出现了类似但明显较轻的效果。
得出的结论是,施用苯巴比妥后小鼠肝脏重量的增加部分归因于细胞增殖(增生)——如实验初期大量有丝分裂象所示,部分归因于肝细胞肿大以及细胞核伴随的多倍体化(肥大)。停药后10天内肝脏重量恢复到正常水平。由于与此同时高倍体细胞核数量减少且没有有丝分裂活性增加的证据,肝脏重量的减轻部分应是由于消除了高倍体肝细胞,在功能亢进刺激停止后这些细胞不再需要……